Eli Lilly and Co. reported fourth-quarter results Wednesday that topped Wall Street expectations, with revenue of $19.3 billion — up 43% from the same quarter a year ago, driven by growth in sales of ...
Amazon has made a quiet move that could reshape how Americans access weight-loss drugs, and several companies stand to ...
Amazon Pharmacy is offering customers cash-pay pricing starting at $299 per month for the 2.5 mg KwikPen starter dose. Amazon Pharmacy has been delivering GLP-1 medications since 2021 and works with ...
Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) have made headlines over the past few years for selling one of the world's most in-demand products: weight loss drugs. Lilly is the maker of ...
Federal regulators on Wednesday approved Eli Lilly’s new weight-loss pill, a second daily oral medication to treat obesity ...
GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that it is working with Eli ...
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 6.3% in the afternoon session after investment bank HSBC ...
New 7.2 mg Wegovy dose launches Tuesday at lower cash price as Novo targets stronger efficacy and broader access.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results